Major depressive disorder.
Conditions
Interventions
Intervention 1: Intervention group: first? use Trazadone drug. Intervention 2: Intervention group: second
use Quetiapine drug. Intervention 3: Control group: thirth
use placebo.
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient who suffering major depressive disorder according to DSM _V criteria with minimum score 20 on the hamilton depression scale .not taking other drugs to control sleepi Not suffering from cardiovascular disease. Kidney. Diabetes Not taking other drugs to control Informed constant to participate in the study
Exclusion criteria
Exclusion criteria: No depression disorder (MDD) Suffering from cardiovascular disease Suffering from kidney . Diabetes disease Dissatisfaction of the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in Hamilton questionnaire. Timepoint: The beginning of the study and 15 and 30 days after start of the medicine. Method of measurement: Hamilton questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of depression. Timepoint: The beginning of the study and 15 and 30 days after start of the medicine. Method of measurement: Hamilton questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rahami
Yasouj University of Medical Sciences
Outcome results
None listed